Closed-Angle Glaucoma

Understanding Closed-Angle Glaucoma

Closed-Angle Glaucoma is a type of glaucoma characterized by the narrowing or closure of the drainage angle in the eye, leading to impaired fluid outflow and elevated intraocular pressure (IOP). This condition can manifest in several forms, including acute Closed-Angle Glaucoma, chronic Closed-Angle Glaucoma, and intermittent Closed-Angle Glaucoma, each with its own unique clinical presentation and management challenges.

Types and Diagnosis

Acute Closed-Angle Glaucoma typically presents with sudden and severe symptoms, such as eye pain, headache, blurred vision, and nausea. It occurs when the drainage angle becomes completely blocked, leading to a rapid increase in IOP. Chronic Closed-Angle Glaucoma, on the other hand, develops gradually over time as the angle narrows progressively. Patients may experience intermittent episodes of elevated IOP and symptoms such as mild discomfort, halos around lights, and gradual vision loss.

Diagnosis of Closed-Angle Glaucoma involves a comprehensive eye examination, including measurement of IOP, assessment of the angle structures using gonioscopy, evaluation of the optic nerve head, and visual field testing. Identification of the type of angle closure, along with the severity and potential risk factors, is essential for guiding treatment decisions and preventing vision loss.

Retyne Infrared Eye Treatment for Closed-Angle Glaucoma

The Retyne Infrared Eye treatment mask offers a non-invasive therapeutic option for managing Closed-Angle Glaucoma, particularly in cases where traditional treatments may be challenging or contraindicated. Program #2 on the Retyne controller utilizes invisible infrared light therapy, which has been shown to have anti-inflammatory and vasodilatory effects. In Closed-Angle Glaucoma, where episodes of elevated IOP can lead to optic nerve damage and vision loss, infrared light therapy may help reduce inflammation, improve blood flow to the optic nerve, and alleviate symptoms.

Closed-Angle Glaucoma poses significant risks to vision and requires prompt diagnosis and management to prevent irreversible damage. The Retyne Infrared Eye treatment mask offers a complementary therapeutic approach for individuals with Closed-Angle Glaucoma, providing invisible infrared light therapy that may help reduce inflammation, improve ocular blood flow, and protect the optic nerve. As part of a comprehensive treatment plan, infrared light therapy has the potential to alleviate symptoms, preserve vision, and improve overall ocular health in patients with Closed-Angle Glaucoma. Early detection, timely intervention, and regular monitoring are essential for optimizing outcomes in these individuals.

The Retyne eye treatment mask harnesses a series of frequencies (0.07, 0.12, 0.6, 0.87, 2.25, 22.5, 187.5, 396.5, 587.5, 696.5) specifically tailored for addressing Closed-Angle Glaucoma. These frequencies have been carefully selected for their efficacy in managing and treating this condition.

Retyne's approach involves translating each frequency into invisible infrared light output, representing a novel integration of frequencies with light, a pioneering technology developed by Retyne Labs. This innovative method draws inspiration from the pioneering work of Dr. Rife, who identified specific frequencies with healing properties and utilized a light source for their transmission. Building upon current research on invisible infrared technology and leveraging past studies on light transmission via frequency sources, the Retyne eye treatment mask represents a fusion of cutting-edge advancements in the field.

Closed-Angle Glaucoma General Group exists at program 1407 on the International ETDFL frequency list